CoChat

Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study

Open access
Piras de Oliveira, Carolina, Mitchell, Beth D., Fan, Ludi, Garey, Colleen, Liao, Birong, Bispham, Jeoffrey, Vint, Nan, Perez-Nieves, Magaly, Hughes, Allyson, McAuliffe-Fogarty, Alicia · 2021 · Current Medical Research and Opinion

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background Half-unit pens offer the ability to dose insulin more precisely. Information about half-unit pen use and evidence of their benefits and drawbacks is limited. This study aims to characterize people with type 1 diabetes (T1D) who have used (current/former = EVER) vs. those who have never used half-unit pens (NEVER users) and to understand their perspective.Methods An observational cross-sectional online survey was administered through T1D Exchange’s online patient community, myGlu.org, to understand the use of half-unit insulin pens.Results The 278 adult participants (156 EVER, 122 NEVER) had a mean age of 41.8 ± 12.7 years, body mass index of 26.0 ± 3.8 kg/m2, glycated hemoglobin of 6.3% ± 1.0%, and 55% were male. EVER users had T1D for a shorter duration than NEVER users (p < .001). EVER users were less likely to use continuous subcutaneous insulin infusion (p < .001) and more likely to start correcting high blood glucose at a lower level (p < .001) and low blood glucose at a higher level (p < .001). The highest ranked benefits of half-unit pen reported by its current users (N = 131) included prevention of hyperglycemia (40.5%), less anxiety or worry (23.7%), and prevention of hypoglycemia (16.8%).Conclusions Half-unit insulin pen is perceived as an insulin device that may help people with T1D to avoid hypo- and hyperglycemic events and decrease their level of disease worry and anxiety. This study highlights the need for patients and health care providers to understand the benefits of half-unit pens while considering options for individualized diabetes management.

Overview

Integrity signals

Registry

Crossref · 10.1080/03007995.2020.1843423

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 5

  1. Baruah MP., 2011, J Assoc Physicians India, 59, 38
  2. Marcus A., 2008, Medscape J Med, 10, 120
  3. 2019, Diabetes Care, 42, S139
  4. Piscopo MA, 2003, Acta Bio-Medica: Atenei Parmensis, 74, 21
  5. Chandran A, 2015, Am Health Drug Benefits, 8, 148

Cited by

See all 9

Metadata

Authors
Piras de Oliveira, C., Mitchell, B. D., Fan, L., Garey, C., Liao, B., Bispham, J., Vint, N., Perez-Nieves, M., Hughes, A., & McAuliffe-Fogarty, A.
Affiliations
  • Eli Lilly and Company, Indianapolis, IN, USA
  • Eli Lilly (United States) (US)
  • T1D Exchange (US)
  • T1D Exchange, Boston, MA, USA
Venue
Current Medical Research and Opinion
Published
2020-11-16
Volume
37
Issue
1
Pages
45-51
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W3094678772
Cited by
9
References
19
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • Current Medical Research and Opinion (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, patient perspectives, hypoglycemia prevention, hyperglycemia prevention, insulin pump therapy
MeSH terms
Adult, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Patient Acceptance of Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study. https://app.cochat.ai/papers/10.1080/03007995.2020.1843423
The paper
Piras de Oliveira, C., Mitchell, B. D., Fan, L., Garey, C., Liao, B., Bispham, J., Vint, N., Perez-Nieves, M., Hughes, A., & McAuliffe-Fogarty, A. (2021). Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2020.1843423

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.